Yeo, Tianrong http://orcid.org/0000-0002-3648-0953
Siew, Rachel Wan En
Gulam, Muhammad Yaaseen
Tye, Janis Siew Noi
Aw, Amelia Yun Yi
Sivalingam, Thanushiree
Peng, Xuejuan
Yong, Kok Pin
Saffari, Seyed Ehsan
Chao, Yinxia
Tan, Kevin
Funding for this research was provided by:
National Medical Research Council (MOH-TA20nov-002, CSAINV20nov-0015, OFLCG18May-0026)
Article History
Received: 21 December 2022
Revised: 26 March 2023
Accepted: 27 March 2023
First Online: 7 April 2023
Declarations
:
: Tianrong Yeo has received honoraria from ASNA, Edanz Pharma, Euroimmun AG, Merck, Novartis, Terumo BCT for consulting services and speaker’s fees, and research grants from the National Medical Research Council (NMRC Singapore) and Roche. He has also received travel grants from UCB, Merck and PACTRIMS, and travel awards from ACTRIMS, ECTRIMS and Orebro University. Kevin Tan has received travel grants and compensation from Novartis, Merck, Sanofi, Eisai, Viela Bio and Roche for consulting services. Rachel Wan En Siew, Muhammad Yaaseen Gulam, Janis Siew Noi Tye, Amelia Yun Yi Aw, Thanushiree Sivalingam, Xuejuan Peng, Kok Pin Yong, Seyed Ehsan Saffari, and Yinxia Chao report no competing interests.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. This study was approved by the Institutional Review Board at SingHealth (CIRB number 2020/2410, 2021/2222).
: Written informed consent was obtained from all patients in the study.
Free to read: This content has been made available to all.